References
- National Institute of Neurological Diseases and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med.333, 1581–1587 (1995).
- Alberts MJ, Hademenos G, Latchaw RE et al. For the Brain Attack Coalition. Recommendations for the establishment of primary stroke centers. JAMA283, 3102–3109 (2000).
- Grotta JC, Burgin WS, El-Mitwalli A et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch. Neurol.58, 2009–2013 (2001).
- Levine SR, Gorman M. Telestroke: the application of telemedicine for stroke. Stroke30, 464–469 (1999).
- LaMonte MP, Bahouth MN, Hu P et al. Telemedicine for acute stroke: triumphs and pitfalls. Stroke34, 725–728 (2003).
- Wang DZ, Rose JA, Honings DS, Garwacki DJ, Milbrandt JC. Treating acute stroke patients with intravenous tPA: the OSF stroke network experience. Stroke31, 77–81 (2000).
- Audebert HJ, Kukla C, von Claranau SC et al. Telemedicine for safe and extended use of thrombolysis is stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPIS) in Bavaria. Stroke36, 287–291 (2005).
- Vaishnav AG, Pettigrew LC, Ryan S. Telephonic expert guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural community hospitals. Presented at: American Academy of Neurology 59th Annual Meeting. Boston, MA, USA, 28 April–5 May 2007 (Abstract).